Incyte Corp (INCY)
68.91
+1.85
(+2.76%)
USD |
NASDAQ |
Dec 20, 16:00
69.03
+0.12
(+0.17%)
After-Hours: 20:00
Incyte Profit Margin (Quarterly): 9.36% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 14.22% |
| Pfizer Inc | 25.22% |
| Exelixis Inc | 21.87% |
| Insmed Inc | -236.0% |
| Sage Therapeutics Inc | -788.1% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.75% |
| Return on Assets | 0.54% |
| Return on Invested Capital | 0.75% |
| Gross Profit Margin (Quarterly) | 92.44% |
| Operating Margin (Quarterly) | 14.90% |
| Return on Net Operating Assets | 1.76% |